Arcturus Therapeutics Holdings Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Arcturus Therapeutics Holdings Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Arcturus Therapeutics Holdings Inc. Operating Margin for the quarter ending September 30, 2024 was -50.2 %, a 342% decline year-over-year.
  • Arcturus Therapeutics Holdings Inc. annual Operating Margin for 2023 was -46.9 %, a 893% decline from 2022.
  • Arcturus Therapeutics Holdings Inc. annual Operating Margin for 2022 was 5.91 %.
  • Arcturus Therapeutics Holdings Inc. annual Operating Margin for 2021 was -1.64K %, a 119% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -50.2 -71 -342% Jul 1, 2024 Sep 30, 2024
Q2 2024 -54.4 -71 -427% Apr 1, 2024 Jun 30, 2024
Q1 2024 -99.1 -127 -460% Jan 1, 2024 Mar 31, 2024
Q4 2023 -46.9 -52.8 -893% Oct 1, 2023 Dec 31, 2023
Q3 2023 20.8 +306 Jul 1, 2023 Sep 30, 2023
Q2 2023 16.7 +421 Apr 1, 2023 Jun 30, 2023
Q1 2023 27.5 +1.29K Jan 1, 2023 Mar 31, 2023
Q4 2022 5.91 +1.65K Oct 1, 2022 Dec 31, 2022
Q3 2022 -285 +1.94K +87.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -404 +1.47K +78.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.26K +63.7 +4.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.64K -892 -119% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.23K -1.73K -347% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.88K -1.54K -457% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.33K -1.18K -790% Jan 1, 2021 Mar 31, 2021
Q4 2020 -750 -627 -511% Oct 1, 2020 Dec 31, 2020
Q3 2020 -499 Jul 1, 2020 Sep 30, 2020
Q2 2020 -337 Apr 1, 2020 Jun 30, 2020
Q1 2020 -149 Jan 1, 2020 Mar 31, 2020
Q4 2019 -123 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.